Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_123